Dow Up 2.00% Nasdaq Up 1.66%

Vertex Pharmaceuticals Incorporated (VRTX)

-NasdaqGS
83.23 Up 3.52(4.42%) Feb 12, 4:00PM EST
|After Hours : 83.25 Up 0.02 (0.02%) Feb 12, 5:04PM EST
Prev Close:79.71
Open:81.94
Bid:83.30 x 100
Ask:117.77 x 300
1y Target Est:132.57
Beta:1.83291
Earnings Date:Apr 27 - May 2 (Est.)
Day's Range:79.50 - 83.81
52wk Range:78.51 - 143.45
Volume:2,771,696
Avg Vol (3m):2,337,080
Market Cap:20.50B
P/E (ttm):N/A
EPS (ttm):-2.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VRTXUp 4.42%20.50B
PTCTUp 5.28%874.27M
BMYUp 1.14%100.43B
MRKUp 0.37%136.97B

Key Statistics

Forward P/E (1 yr):15.85
P/S (ttm):19.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :2.17
Quarterly EPS Est (Mar-16) :0.32
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):0.63

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback